Literature DB >> 11752839

Basic pathophysiologic mechanisms in irritable bowel syndrome.

E A Mayer1, B D Naliboff, L Chang.   

Abstract

Converging evidence supports the concept that the irritable bowel syndrome (IBS) symptom complex results from altered regulation of gastrointestinal motility and epithelial function, as well as an altered perception of visceral events. Despite similar symptoms, there is likely heterogeneity of underlying dysfunction and pathogenesis in different subgroups of IBS patients: the syndrome may be produced by primary alterations in the central nervous system (CNS; top down model), or by primary alterations in the periphery (bottom up model), or by a combination of both. One plausible mechanism by which alterations in the CNS result in symptoms, is the enhanced responsiveness of central stress/emotion circuits. The physiological effects of psychological and physical stressors on gut function and brain-gut interactions are mediated by outputs of the emotional motor system in terms of autonomic, neuroendocrine, attentional and pain modulatory responses. IBS patients show an enhanced responsiveness of this system manifesting in altered modulation of gastrointestinal motility, secretion, immune function and in alterations in the perceptual and emotional response to visceral events. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11752839     DOI: 10.1159/000050682

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  20 in total

1.  Peripheral sensitization of sensory neurons.

Authors:  Victor V Chaban
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

2.  Autonomic activity and somatic symptoms in response to success vs. failure on a cognitive task: a comparison of chronic abdominal pain patients and well children.

Authors:  Martina Puzanovova; Patrick G Arbogast; Craig A Smith; Julia Anderson; André Diedrich; Lynn S Walker
Journal:  J Psychosom Res       Date:  2009-04-15       Impact factor: 3.006

3.  Serum correlates of the placebo effect in irritable bowel syndrome.

Authors:  E Kokkotou; L A Conboy; D C Ziogas; M T Quilty; J M Kelley; R B Davis; A J Lembo; T J Kaptchuk
Journal:  Neurogastroenterol Motil       Date:  2009-12-22       Impact factor: 3.598

4.  Estrogen modulation of visceral nociceptors.

Authors:  Victor Chaban
Journal:  Curr Trends Neurol       Date:  2013

Review 5.  Irritable bowel syndrome: a clinical review.

Authors:  Rosa L S Soares
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 6.  Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model.

Authors:  Cristina Stasi; Massimo Rosselli; Massimo Bellini; Giacomo Laffi; Stefano Milani
Journal:  J Gastroenterol       Date:  2012-07-06       Impact factor: 7.527

7.  Neuroimmune interaction in inflammatory diseases.

Authors:  Peyman Otmishi; Joshiah Gordon; Seraj El-Oshar; Huafeng Li; Juan Guardiola; Mohamed Saad; Mary Proctor; Jerry Yu
Journal:  Clin Med Circ Respirat Pulm Med       Date:  2008-04-29

Review 8.  Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome.

Authors:  C Stasi; M Bellini; G Bassotti; C Blandizzi; S Milani
Journal:  Tech Coloproctol       Date:  2014-01-15       Impact factor: 3.781

9.  Seirogan (wood creosote) inhibits stress-induced ion secretion in rat intestinal epithelium.

Authors:  Koji Ataka; Tomoo Kuge; Kalina Venkova; Beverley Greenwood-Van Meerveld
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

Review 10.  Use and abuse of hydrogen breath tests.

Authors:  M Simrén; P-O Stotzer
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.